BioClonal

BioClonal specializes in the design and customization of monoclonal antibodies for therapeutic applications, utilizing advanced immunogen design and immunization techniques to enhance antibody discovery. The company addresses the inefficiencies of traditional immunization methods, enabling the development of effective therapies for oncology and immunology.

Traction 5/10

Zaragoza, Spain · HQ

Founded 202291K+ followers

Biotechnology

Updated 7 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Paula Garfella Lorente

CEO

Product

Features

BioClonal specializes in the design and customization of monoclonal antibodies for therapeutic applications, utilizing advanced immunogen design and immunization techniques to enhance antibody discovery. The company addresses the inefficiencies of traditional immunization methods, enabling the development of effective therapies for oncology and immunology.